Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Patel, Nilam
SIGLEC, NCT05839041: A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)	Active, not recruiting	2	300	US	AVD-104, Avacincaptad	Aviceda Therapeutics, Inc.	Geographic Atrophy of the Macula, Macular Degeneration	09/25	09/26
Montgomery, Sara
SIGLEC, NCT05839041: A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)	Active, not recruiting	2	300	US	AVD-104, Avacincaptad	Aviceda Therapeutics, Inc.	Geographic Atrophy of the Macula, Macular Degeneration	09/25	09/26